Trump Bursts Biotech ETFs’ Bubble

Biotechnology stocks and sector-related exchange traded funds retreated Tuesday after President-elect Donald Trump vowed to “bring down drug prices.” The iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), the largest biotech ETF by assets, declined 3.3% Tuesday, falling back below its long-term, 200-day simple moving average. IBB has rebounded 9.0% over the past month after Trump won…Click to read more at ETFtrends.com.